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Human tumours frequently contain hypoxic regions which develop
as a consequence of inadequate blood supply to rapidly growing
tissue with metabolic demands. In response to hypoxic stress, tumour
cells have been shown to activate a variety of rescue mechanisms,
including the up-regulation of genes which code for angiogenesis
factors, transcription factors, glucose transporters and glycolytic
enzymes (Hochachka et al, 1996). The ability to develop new blood
supply and to utilize glucose as an energy source increases the prob-
ability of tumour cell survival under oxygen-limiting conditions.
Among normal tissues, the production of erythropoietin by the
kidney and liver in response to hypoxia is the most familiar physio-
logical example of oxygen-regulated gene expression. Normal
tissues also respond to hypoxia by regulating the rate at which
oxygen is consumed. Skeletal muscle and normal brain provide the
best examples of the variation in response to hypoxic stress which
exists among normal tissues. Skeletal muscle decreases oxygen
consumption rate as the supply of oxygen becomes limiting, giving
rise to the designation of muscle as an ‘oxygen-conforming’ tissue
(Hochachka and Guppy, 1987). In contrast, the normal brain
continues to consume oxygen at a steady rate which is independent
of oxygen availability over a broad range of oxygen concentrations.
Normal brain is thus an ‘oxygen-regulatory’ tissue (Hochachka and
Guppy, 1987). The oxygen consumption rates of tumours have been
examined in vivo. In general, 15O2-PET studies show lower extrac-
tion ratio for oxygen in gliomas than in the contralateral, normal
hemisphere (Lammertsma et al, 1985; Brooks, 1990).
Human malignant gliomas are the most common brain tumour
among adults. Necrotic regions within the tumour mass are
diagnostic of high-grade gliomas and are believed to arise from
microregional exhaustion of oxygen and/or other nutrients. In our
previous studies of human malignant glioma cell lines grown as
xenografted tumours and labelled in vivo with the hypoxia marker
[3H]misonidazole, we observed that a significant proportion of the
necrotic regions in these tumours were not associated with hypoxia
(Parliament et al, 1997). It is generally accepted that the relative
oxygen concentration at any point ‘p’ in a tumour is determined by
the supply of oxygen from a functional capillary and the rate at which
oxygen is consumed by the cells which lie along the path of oxygen
diffusion to ‘p’ (see, for example, Dewhirst et al, 1994). To explain
the variable presence of hypoxic regions adjacent to necrosis, we
proposed a model in which the oxygen consumption rate of tumours
conforms to either ‘oxygen regulatory’ or ‘oxygen conforming’
phenotypes. In the oxygen regulatory model, malignant glioma cells
maintain a relatively constant rate of oxygen consumption at all
points along the path of diffusion of oxygen from the blood supply,
leading to the development of an oxygen gradient as one moves
distally to the blood supply. As oxygen becomes a limiting substrate,
regions of hypoxia develop at points distant from the vasculature and
cell death and necrosis occurs when the oxygen supply is exhausted.
This model is consistent with the concept that gliomas utilize oxygen
in a manner similar to that of normal brain, and is supported by our
previous observations of hypoxic regions adjacent to necrosis in
tumour xenografts (Parliament et al, 1997). However, in some
regions of xenografted tumours, a pattern of tumour necrosis in the
absence of hypoxia suggested that malignant gliomas can also
behave as oxygen conformers. Under this condition, diminished
oxygen supply to tumour cells distant from blood vessels may be
detected intracellularly by an ‘oxygen sensor’ (Chandel et al, 1997),
resulting in a number of signalling events including ultimately
decreased respiration. Because less oxygen is consumed, its diffusion
distance is increased and hypoxic regions, when they occur, develop
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oxygen regulatory model. Cellular necrosis develops, but as a conse-
quence of the exhaustion of some essential nutrient(s) other than
oxygen (e.g. glucose). To determine whether this model is correct, we
selected human glioma cells which exhibit different patterns of
hypoxia adjacent to necrosis, and measured both oxygen consump-
tion rate and vascular endothelial growth factor (VEGF) gene expres-
sion under in vitro conditions which permitted the concentration of
oxygen in the atmosphere to be precisely regulated.
MATERIALS AND METHODS
Cell lines and xenografts
Details of the origin and characterization of the glioma cell lines
used in this study have been previously published (Allalunis-
Turner et al, 1992; Parliament et al, 1997). All animal experiments
were performed according to guidelines for the use of animals in
research established by the Canadian Council for Animal Care.
Details of the initiation and growth of tumour xenografts were as
previously described (Parliament et al, 1997).
Hypoxic cultures and oxygen consumption rate
To study the effect of changes in oxygen tension on oxygen
consumption rate and vascular endothelial growth factor (VEGF)
expression, a gas-exchange manifold system composed of a series
of leak-proof aluminium chambers (Koch et al, 1979) was used to
create atmospheres of varying proportions of oxygen in 5% carbon
dioxide/95% nitrogen. Cells were trypsinized from exponentially
growing monolayer cultures, seeded onto glass plates and incu-
bated under standard conditions (18% oxygen) or in aluminium
chambers under moderately hypoxic conditions corresponding to
2% or 0.6% oxygen. Sealed chambers were incubated at 37°C for
4 days. At the end of the incubation period, plates were removed
from the chambers and the cells were trypsinized, washed and
resuspended in complete medium. The oxygen consumption rate
was determined using a Clark-type electrode (Koch, 1984) which
measured the oxygen concentration continuously in the cell
suspension in a specially designed spinner chamber held in a 37°C
water bath. The oxygen consumption was calculated from the
linear portion of the oxygen consumption curve and was deter-
mined within the first hour after electrode stabilization. In other
experiments, a colony-forming assay was used as previously
described (Allalunis-Turner et al, 1992) to assess the proportion of
clonogenic cells recovered after growth under hypoxic conditions.
Northern blotting
Total RNA was isolated from cells cultured for 5 h under aerobic
or hypoxic conditions using the guanidinium/silica gel column
method (Qiagen). Twenty micrograms of total RNA was elec-
trophoresed in each lane. After transfer, the blots were hybridized
with 32P-random-labelled probes to b-actin or VEGF (a kind gift
from Dr Harold Dvorak). The 204-bp human VEGF probe was
originally prepared by reverse transcription polymerase chain
reaction (PCR) with oligonucleotide primers [(forward): 5¢-
CGCGGATCCAGGAGTACCCTGATGAG-3¢; (reverse) 5¢-
CCGGAATTCACATTTGTTGTGCTGT-3¢] based on the human
VEGF sequence (Berse et al, 1992). This probe was designed
specifically to recognize all VEGF transcripts and does not
discriminate among alternatively spliced transcripts (Berse et al,
1992). To quantify changes in VEGF mRNA expression, the radio-
graphic film used to detect 32P decay was scanned using a
PDQUEST densitometer (PDI, Huntington Station, NY, USA).
Optical densities of the regions of the film corresponding to the
VEGF and b-actin bands were determined using PDI Quantity One
scanning and analysis software. VEGF mRNA optical densities
were normalized using b-actin mRNA of each samples as a control.
Increases in mRNA after exposure to hypoxic conditions are
expressed as a percentage of the aerobic (18% oxygen) cultures.
Immunohistochemistry
Cells were grown for 24 h in aluminium chambers in atmospheres
of 18%, 2% or 0.6% oxygen as described above. After trypsiniza-
tion and washing, cells were spun onto glass microscope slides
(Shandon Cytospin) and fixed with methacarn, a solution of
absolute methanol (60%), chloroform (30%) and glacial acetic
acid (10%). A polyclonal antibody (Santa Cruz), which recognized
the 121, 165 and 189 isoforms of VEGF, and the Fast Red detec-
tion system (BioGenex) were used to analyse VEGF protein
expression. A cell showing one or more foci of intense red staining
was judged to be positive for VEGF protein expression. For each
cell line, ³ 500 cells were examined and the percentage of cells
staining positive for VEGF expression was determined.
Statistics
A computer based t-test (StatView for the Mac) was used to
evaluate the significance of differences observed.
RESULTS
Oxygen consumption rates
The effect of moderate hypoxia on oxygen consumption rate was
determined for human glioma cells which exhibit different patterns
of hypoxia adjacent to necrosis in vivo. Figure 1A plots the oxygen
consumption rates as a function of percentage of oxygen in the gas
phase of the incubation chambers. Included in this figure for refer-
ence are the oxygen consumption rates previously determined for
xenograft explants established from these same glioma cell lines
(Parliament et al, 1997). For four parental (M006 and M059K) and
xenograft-derived (M006x and M059Kx) cell lines, the mean
values of the oxygen consumption rates measured under fully
aerobic conditions (18% oxygen) were significantly greater (P <
0.05) than the mean values determined for cells incubated in
atmospheres of 2% or 0.6% oxygen for 4 days. In contrast, the
mean oxygen consumption rate of M010b cells showed a greater
variability in response to reduced oxygen, with no values
measured under hypoxic conditions being statistically different
from that of the aerobic controls.
To facilitate comparisons, the oxygen consumption rate of each
cell line was normalized to that previously determined for the
corresponding tumour xenograft explant (Figure 1B). Cells grown
under standard incubator conditions (18% oxygen) consumed
oxygen at rates 2.4- to 4.8-fold greater than those measured for
freshly dissociated tumour explants. When cells grown in 18%
oxygen were transferred to modestly hypoxic conditions for
4 days, oxygen consumption rates were reduced. The oxygen
consumption rates of cells incubated at 2% oxygen differed from
those of the corresponding tumour explants by factors of 0.4–2.4.
At 0.6% oxygen, the oxygen consumption rates approached those
of the tumour explants (0.5–1.4).
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To determine whether the decrease in oxygen consumption rate
was the result of cell death, the clonogenic cell survival of M006
and M010b cells after exposure to 4 days of moderate hypoxia was
determined (Figure 2). Compared with control cells maintained
at 18% oxygen, exposure of M010b cells to moderate hypoxia
(0.66% oxygen) resulted in a significant (P < 0.01) decrease in the
proportion of clonogenic cells, despite the ability of M010b cells
to maintain a relatively steady rate of oxygen consumption. In
contrast, hypoxia did not reduce the proportion of clonogens in the
M006 cell line, which significantly decreased oxygen utilization in
response to hypoxia.
VEGF mRNA expression
We tested whether oxygen regulates VEGF mRNA expression
over the range of concentrations likely to exist in human tumours
and whether this expression differs in glioma cells which vary in
their ability to reduce cellular respiration in response to hypoxia.
Low levels of VEGF mRNA were observed in M006 and M010b
cells cultured under fully aerobic conditions (Figure 3). Under
hypoxic conditions, an eight- to tenfold increase in VEGF message
was observed for both cell lines. In contrast, VEGF message was
constituitively expressed in aerobic M059K cells and was not
further increased by hypoxia.
To address the question of whether chronic exposure to hypoxia
can alter the expression of hypoxia-responsive genes, M006´
tumour spheroids were cultured at 0.6% oxygen for 13 days,
giving rise to the cell line designated M006´Lo. In comparison
with the parental line (M006´) in which moderate hypoxia
increased VEGF message ~15-fold, M006´Lo cells showed
constitutive VEGF mRNA expression which was only slightly
(i.e. 1.5 – twofold) increased by hypoxia (Figure 4).
VEGF protein expression
To assess whether differences in VEGF mRNA expression observed
among the three glioma cell lines reflected differences in protein
expression, immunohistochemical staining of VEGF protein was
performed using cells maintained under modestly hypoxic condi-
tions for 24 h. Compared with aerobic control, exposure of M010bx,
M006x and M059Kx cells to atmospheres of 2% oxygen (Figure 5)
or 0.6% oxygen (data not shown) resulted in an increased
percentage of cells staining positive for VEGF protein expression.
The percentage of VEGF-positive cells under conditions of 18%,
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Figure 1 (A) Oxygen consumption rates (mMeell–1 h–1) of malignant glioma
cells grown in atmospheres of 18%, 2% or 0.6% oxygen. A: Results from
four or more replicate experiments are expressed as means ± s.d.; l l =
M010b; n n = M006; n = M006x; s s = M059K; s = M059Kx. Oxygen rates
previously determined for tumour xenograft explants (Parliament et al, 1997)
are provided for comparison. When fewer than five points are shown, the
symbols overlap, and only one (or two) symbols are shown. The following
P-values were obtained when the differences in mean oxygen consumption
rate of cells incubated under 18% vs. 2% oxygen and 18% vs. 0.6% oxygen,
respectively, were compared: M006, P < 0.03, P < 0.02; M006x, P < 0.03,
P < 0.003; M059K, P < 0.02, P < 0.005; M059K´, P <0.02, P < 0.004;
M010b, P > 0.1, P > 0.1. (B) The oxygen consumption rate of each cell line
shown in A was normalized to that previously determined for the
corresponding tumour xenograft explant
Figure 2 Colony-forming cells recovered from cultures of M010b (l l) or
M006 (n n) cells grown in atmospheres of 18%, 2% and 0.6% oxygen. Results
from four or more replicate experiments are expressed as means ± s.d. and
are provided as a percentage of the 18% oxygen value. *P < 0.01
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Figure 3 Northern blot analysis of VEGF mRNA expression in M059Kx,
M010bx and M006x glioma cells exposed for 5 h to atmospheres of 18%, 2%
or 0.6% oxygenOxygen consumption and VEGF in glioma 107
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2% or 0.6% oxygen, respectively, were M010bx (21%, 75%, 62%),
M006x (17%, 97%, 92%) and M059Kx (60%, 99%, 56%). The rela-
tively increased (60%) positive staining for VEGF observed in
aerobic M059Kx cells was consistent with the observed constitutive
aerobic expression of VEGF mRNA in this cell line.
DISCUSSION
We have previously shown that the oxygen consumption rates of
human malignant glioma cell lines grown as xenografts, in which the
pO2 values would be expected to range between roughly 0.2% and
8%, were significantly lower than those determined for the same cell
lines grown in vitro in which the oxygen in the medium was in near
equilibrium with that of the atmosphere (18% oxygen) (Parliament et
al, 1997). This suggested that malignant glioma cells may possess a
functional oxygen sensor that allows the rates of oxygen consump-
tion to conform to oxygen availability in a manner similar to that
reported for normal hepatocytes. To test this hypothesis, we
measured oxygen consumption rates of human malignant glioma cell
lines after growth in vitro under fully aerobic (18% oxygen) or
modestly hypoxic (2% and 0.6% oxygen) conditions. In five tumour
cell lines tested, decreased oxygen availability resulted in decreased
rates of oxygen utilization, although the magnitude of the response
varied greatly among the cell lines. The decreased oxygen consump-
tion rates were not attributable to loss of cell viability because on
average >90% of the cells recovered from the incubation chambers
were viable as assessed by a dye exclusion assay (data not shown).
These results are in marked contrast to previous studies of the oxygen
dependence of cellular respiration. Several investigators have shown
that the rate of oxygen consumption remains independent of oxygen
tension down to very low levels of oxygen (Km < 1 mM) (Froese,
1962; Boag, 1970; Erecinska and Wilson, 1982). However, the
experimental design of the present work differs from previous studies
in that cells were maintained under hypoxic conditions for 4 days
before determination of oxygen consumption rate. In earlier studies,
oxygen consumption rates were determined for cells maintained in
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Figure 4 Northern blot analysis of VEGF mRNA expression in parental
(M006x) and hypoxia-adapted (M006xLo) glioma cells exposed for 5 h to
atmospheres of 18%, 2% or 0.6% oxygen
Figure 5 Immunohistochemical analysis of VEGF protein expression in human malignant glioma cells cultured for 24 h under aerobic or hypoxic conditions.
(A) M059Kx, 18% oxygen; (B) M059Kx, 2% oxygen; (C) M010bx, 18% oxygen; (D) M010bx, 2% oxygen; (E) M006x, 18% oxygen; (F) M006x, 2% oxygenclosed systems for a few hours. The extended hypoxic incubation
period used in our studies may have allowed for the activation of a
cascade of hypoxic defence mechanisms. In addition, the response to
hypoxic stress in malignant glioma cells may be intrinsically
different from that of tumour cells grown as ascites.
As an initial response to oxygen deficit, hypoxia-tolerant cells
suppress cellular ATP-demand and -utilization pathways
(Hochachka et al, 1996). In recent studies, Chandel et al (1997)
have shown that normal hepatocytes regulate their cellular respira-
tion as a function of oxygen availability, with reduction of oxygen
utilization under physiological levels of hypoxia and restoration of
basal levels upon reoxygenation. Further, the absence of a signifi-
cant increase in lactate production during hypoxic incubation
suggested that anaerobic ATP production did not contribute to the
energy supply. For hepatocytes, reversible changes in the Vmax of
cytochrome  c oxidase in response to hypoxia suggests that
cytochrome c oxidase may function as an oxygen sensor. The
putative oxygen sensor in tumour cells remains to be identified,
however cytochrome c oxidase or other members of the electron
transport chain are likely candidates.
The ability to regulate cellular respiration could confer a signif-
icant survival advantage for tumour cells. Studies by Dewhirst
et al (1994) have provided evidence that such regulation may exist
in tumours in situ. Using a rat mammary adenocarcinoma model,
they have shown that significant variations in oxygen consumption
occur at the microregional level, suggesting that tumour cells can
modulate cellular respiration in response to local variations in
oxygen availability. Our in vitro results showing reduced oxygen
consumption in response to hypoxia are consistent with the studies
of Dewhirst et al (1994), and provide additional support for the
hypothesis that microregional control of cellular respiration is a
component of the hypoxic stress response.
In principle, the ability to modulate tumour cell respiration
would provide a mechanism to improve the therapeutic response to
ionizing radiation and certain chemotherapeutic agents. Using a
theoretical simulation of oxygen transport in a rat tumour model,
Secomb et al (1995) have calculated that 30% reduction in oxygen
consumption rate would be sufficient to eliminate tumour hypoxia.
The data presented in this study suggest that: (i) the ability of
malignant glioma cell lines to modulate their rates of respiration
varies considerably; and (ii) reductions in oxygen consumption rate
calculated for in vitro cell cultures may not adequately predict the
changes likely to occur in vivo. As regards the first point, the base-
line oxygen consumption rates of the cell lines grown under stan-
dard incubator conditions varied by factor of 5. The magnitude of
the difference in oxygen consumption rate observed when cells
were moved from aerobic to hypoxic conditions was greatest for
the cell lines M059K and M059Kx, which have the greatest base-
line oxygen consumption rates. Nonetheless, the theoretical target
of 30% reduction in oxygen consumption rate vis-à-vis that of
aerobic controls was achieved even for the cell line with the lowest
baseline oxygen consumption rate (M010b). However, if one were
to use changes in respiration rate as a means of assessing the feas-
ibility of reduction of oxygen consumption rates of tumours in situ,
then measurement of consumption rates relative to the
baseline values of tumour explants may provide a more relevant
analysis. For the glioma cells in this study, the baseline oxygen
consumption rates of freshly dissociated tumour explants varied by
a factor of 3.5. As was the case for cells grown under standard incu-
bator conditions, the M059K tumour explants showed the greatest
rate of oxygen consumption and the M010b tumour explants the
least. When M059K cells were cultured under hypoxic conditions,
their oxygen consumption rate was reduced to approximately one-
half the value of that of the tumour explant. In contrast, hypoxia
(2% and 0.6% oxygen) was unable to reduce the oxygen consump-
tion rate of the M010b cell line relative to the baseline value estab-
lished for M010b tumour explants. Moreover, exposure of M010b
cells to hypoxia (0.6% oxygen) resulted in a significant loss of
colony-forming ability. Thus, it is unlikely that the failure to reduce
oxygen consumption rate below that of the tumour explant was due
to insufficient hypoxic stress. These results suggest that strategies
to improve tumour oxygenation by reducing oxygen consumption
rate may not be effective in tumours which have, on average, a rela-
tively low rate of cellular respiration.
Overall, the variable patterns of oxygen utilization described for
these glioma cell lines in vitro are consistent with those observed for
the same cells grown as xenografted tumours. In M010b xenografts,
virtually all areas of necrosis were associated with severe hypoxia
(Parliament et al, 1997). In contrast, in M006 and M059K tumours,
~20–50% of necrotic regions showed no evidence of severe
hypoxia. This suggests that the M006 and M059K cell lines contain
subpopulations of tumour cells capable of modulating oxygen
consumption in vivo, whereas subpopulations of cells with such
properties may be less abundant in the M010b cell line. Although in
vitro determinations of oxygen consumption rates are useful in iden-
tifying overall responses to hypoxic stress, such measurements will
fail to detect tumour subpopulations which may differ in their
patterns of oxygen utilization. To address these questions, experi-
ments to identify intratumoural differences in response to hypoxia
are currently underway using clonally derived cells.
The ability to up-regulate angiogenesis factors is a critical compo-
nent of a tumour’s ability to respond to hypoxic stress by developing
new vasculature supply (reviewed in Hanahan and Folkman, 1996).
VEGF is a potent angiogenic factor (reviewed in Ferrara et al, 1992;
and in Dvorak et al, 1995). In human cells, four alternatively spliced
transcripts encode polypeptides of 121, 165, 189 and 201 amino
acids. VEGF121 and VEGF165 are secreted in soluble form and
promote endothelial cell mitogenesis. VEGF185, VEGF206 and a
percentage of VEGF165 polypeptides are secreted but remain bound
to the cell surface, possibly serving as a reservoir of biologically
active VEGF (Houck et al, 1992). Among human gliomas, VEGF165
is the predominant form (Berkman et al, 1993). The VEGF gene
contains a hypoxia-inducible factor (HIF-1) binding site within the 5¢
enhancer region (Ema et al, 1997; Levy et al, 1997) and has been
demonstrated to be transcriptionally activated in response to hypoxia
(Iliopoulos et al, 1996; Bussolino et al, 1997; Levy et al, 1997).
Increased levels of both VEGF mRNA ligand and receptor have been
reported in a variety of human cancers (Ohta et al, 1996; Suzuki et al,
1996; Fontanini et al, 1997; Salver et al, 1997) including glioblas-
toma (Plate et al, 1992, 1994), and may confer a growth advantage
and/or be a marker of aggressive tumour behaviour. In this study, we
tested whether the induction of VEGF mRNA in response to physio-
logically relevant hypoxic conditions would differ among glioma cell
lines. No apparent correlation between the induction of VEGF
expression and the patterns of cellular respiration in response to
hypoxic stress was observed as modest levels of hypoxia increased
production of VEGF mRNA above that found in aerobic cells in both
M006x and M010b cells. The response to hypoxic stress involves
activation of multiple pathways (Hochachka et al, 1996). There is no
reason to expect that all pathways will respond identically. Our data
suggest that the pathways leading to VEGF induction and oxygen
consumption are clearly regulated differently during hypoxic stress.
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In this study, we observed differences in the basal level of
VEGF transcript and protein and in the magnitude of the induction
of VEGF in response to hypoxia. VEGF mRNA was constitutively
expressed in M059Kx and M006xLo cells, and its expression was
not further increased by hypoxia. White et al (1995) reported high
levels of constitutive VEGF message expression in some human
tumour cell lines, and have shown that such VEGF-overexpressing
cells are least responsive to hypoxia. In their comparison of intra-
cellular VEGF concentrations in the HCT-8 colon carcinoma cell
line and its clonal derivative clone A, Leith and Michelson (1995)
noted similar differences in both the basal levels of VEGF and in
its rate of secretion in response to hypoxia. Mechanisms involving
post-transcriptional regulation of VEGF leading to increased
message stability are believed to contribute to constitutive eleva-
tion of VEGF observed in human tumour cell lines (White et al,
1995; Levy et al, 1996, 1997). Experiments to determine whether
the half-life of VEGF mRNA produced by M059Kx and M006xLo
cells is modified are currently underway.
In summary, although others have reported the induction of
VEGF mRNA in human tumour cell lines grown under severely
hypoxic or anoxic conditions, our studies demonstrate that oxygen
levels approximating venous pO2 are sufficient to activate VEGF
transcription. Further, our results suggest that significant intra- and
intertumoral differences in oxygen utilization may exist among
human malignant gliomas and that microregional differences in
oxygenation may result in heterogeneous transcriptional activation
of hypoxia-inducible genes. The influence such differences may
have on therapies designed to exploit tumour hypoxia remains an
intriguing question.
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